Results 1 to 10 of about 764,021 (214)

Artesunate improves DDC-induced cholestatic liver fibrosis through PI3K/Akt/mTOR signaling pathway in mice

open access: yes陆军军医大学学报, 2023
Objective To explore the effect and molecular mechanism of artesunate (ART) on cholestatic liver fibrosis induced by 3, 5-diethoxycarbonyl-1, 4-dihydro-2, 4, 6-collidine (DDC).
TANG Wan   +3 more
doaj   +1 more source

Screening and validation of Hub genes in bile acid-induced hepatocyte response based on transcriptome sequencing

open access: yes陆军军医大学学报, 2023
Objective To screen and verify the Hub genes involved in conjugated bile acid-induced hepatocyte metabolism through transcriptome sequencing analysis. Methods Primary mouse hepatocytes were treated with taurocholic acid (TCA), and the gene expression of ...
ZHANG Mengni   +4 more
doaj   +1 more source

Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity

open access: yesFrontiers in Nutrition, 2022
Recent studies have revealed that sarcopenia is closely associated with obesity and non-alcoholic steatohepatitis (NASH). However, few attempted to explore the cause-and-effect relationship between sarcopenic obesity and NASH.
Zi-Xuan Wang   +9 more
doaj   +1 more source

Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis [PDF]

open access: yesClinical and Molecular Hepatology, 2023
Nonalcoholic steatohepatitis (NASH) is an aggressive form of nonalcoholic fatty liver disease (NAFLD) characterized by steatosis-associated inflammation and liver injury. Without effective treatment or management, NASH can have life-threatening outcomes.
Yi-wen Shi, Jian-Gao Fan
doaj   +1 more source

Fatty liver index associates with relative sarcopenia and GH/ IGF- 1 status in obese subjects [PDF]

open access: yes, 2016
Recently the association between hepatic steatosis and sarcopenia has been described. GH/IGF-1 axis has been postulated to play a role in linking fatty liver and low muscle mass.
Donini, Lorenzo Maria   +5 more
core   +4 more sources

Carrier-free curcumin nanoassemblies for enhancing therapy effects in inflammation related disease

open access: yesMaterials & Design, 2022
Hyperinflammation can lead to tissue injury, organ failure, and even fatalities by overproducing proinflammatory cytokines. The long-term safety and outstanding anti-inflammatory ability of natural products have attracted much attention, but the low ...
Liangjun Zhang   +9 more
doaj   +1 more source

Hepatocyte-targeted hyaluronic acid-polyethyleneimine conjugates for acute liver injury therapy by ROS elimination and inflammation modulation

open access: yesMaterials & Design, 2023
Acute liver injury (ALI) is one of the most important causes of liver failure, and there are no FDA-approved drugs that could therapy late-stage ALI. It has been shown in this study that HA-PEI, a molecule formed by covalently combining HA and PEI, can ...
Mingqiao Li   +10 more
doaj   +1 more source

Unique DUOX2+ACE2+ small cholangiocytes are pathogenic targets for primary biliary cholangitis

open access: yesNature Communications, 2023
The aetiology of primary biliary cholangitis (PBC) remains unclear. Here, the authors find that the numbers of DUOX2 + ACE2 + small cholangiocytes in human and mouse livers are inversely associated with disease severity, and present data indicating that ...
Xi Li   +32 more
doaj   +1 more source

Regulation of Lipid Metabolism by Lamin in Mutation-Related Diseases

open access: yesFrontiers in Pharmacology, 2022
Nuclear lamins, known as type 5 intermediate fibers, are composed of lamin A, lamin C, lamin B1, and lamin B2, which are encoded by LMNA and LMNB genes, respectively.
Yue Peng   +4 more
doaj   +1 more source

In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions

open access: yesLiver Research, 2023
Non-alcoholic fatty liver disease (NAFLD) is characterized by the abnormal buildup of lipids in the liver tissue. Non-alcoholic fatty liver (NAFL) may progress to non-alcoholic steatohepatitis.
Zhixian Zhu   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy